Choo Chee Kong - Significant Ownership

Signature - Title
Choo Chee Kong - Choo Chee Kong / Chairman and Director of CytoMed Therapeutics Limited
Location
Singapore, Singapore
Summary
This page shows a list of all the recent SCHEDULE 13D/G filings made by Choo Chee Kong.

Significant Ownership of Choo Chee Kong

Sym Company Class Ownership Holdings Value Net Change Nb Shares Change % Reporting Name Report Period
GDTC CytoMed Therapeutics Ltd Ordinary Shares 23.17% $6.71M 2.67M Choo Chee Kong Feb 20, 2025

Schedules 13D/G Reported by Choo Chee Kong:

Sym Target Class Ownership Change Current Shares Change Value Reporting name Form Report Period Date Filed
* An asterisk sign (*) next to the price indicates that the price is likely invalid.